Evidence map›Paper›PMID 38266886›Full record

ArticleExperimental gerontology2024

Exercise and inflammatory cytokine regulation among older adults with myeloid malignancies.

Kah Poh Loh, Ying Wang, Chandrika Sanapala, Nikesha Gilmore, Colleen Netherby-Winslow, Jason H Mendler, Jane Liesveld, Eric Huselton, AnnaLynn M Williams, Heidi D Klepin and 5 more

Open access · goldAbstract read
In one paragraph

Article in Experimental gerontology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Feasibility and preliminary effects of mhealth supportive care interventions in adults with myeloid neoplasms: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  2. Trial
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Kah Poh LohJames P. Wilmot Cancer Institute, Rochester, NY, USA; Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: kahpoh_loh@urmc.rochester.edu.
Ying WangDepartment of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: ying_wang@urmc.rochester.edu.
Chandrika SanapalaBurrell College of Osteopathic Medicine, Las Cruces, NM, USA. Electronic address: cxs537@case.edu.
Nikesha GilmoreDivision of Supportive Care in Cancer, Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: nikesha_gilmore@urmc.rochester.edu.
Colleen Netherby-WinslowDivision of Supportive Care in Cancer, Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: colleen_netherby-winslow@urmc.rochester.edu.
Jason H MendlerJames P. Wilmot Cancer Institute, Rochester, NY, USA; Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: jason_mendler@urmc.rochester.edu.
Jane LiesveldJames P. Wilmot Cancer Institute, Rochester, NY, USA; Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: jane_liesveld@urmc.rochester.edu.
Eric HuseltonJames P. Wilmot Cancer Institute, Rochester, NY, USA; Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: eric_huselton@urmc.rochester.edu.
AnnaLynn M WilliamsJames P. Wilmot Cancer Institute, Rochester, NY, USA; Division of Supportive Care in Cancer, Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: annalynn_williams@urmc.rochester.edu.
Heidi D KlepinWake Forest Baptist Comprehensive Cancer Center, Medical Center Blvd, Winston-Salem, NC, USA. Electronic address: hklepin@wakehealth.edu.
Marielle Jensen-BattagliaDepartment of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: marielle_jensenbattaglia@urmc.rochester.edu.
Karen MustianJames P. Wilmot Cancer Institute, Rochester, NY, USA; Division of Supportive Care in Cancer, Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: karen_mustian@urmc.rochester.edu.
Paula VertinoJames P. Wilmot Cancer Institute, Rochester, NY, USA; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: paula_vertino@urmc.rochester.edu.
Martha SusiarjoDepartment of Environmental Medicine, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: martha_susiarjo@urmc.rochester.edu.
Michelle C JanelsinsJames P. Wilmot Cancer Institute, Rochester, NY, USA; Division of Supportive Care in Cancer, Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: michelle_janelsins@urmc.rochester.edu.
University of Rochester Medical Center · USAtrium Health Wake Forest Baptist · US

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI B Paige Lawrence · 1985 to 2026
$42.8M
Geriatric Oncology Research Infrastructure to Improve Clinical CareR33AG059206 · NIA · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WILLIAM DALE, Heidi Diana Klepin · 2020 to 2026
$5.1M
A novel mobile health exercise intervention for older patients with myeloid neoplasmsR00CA237744 · NCI · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2021 to 2023
$747k
A Phase II Randomized Placebo Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Physical Frailty and Tumor Necrosis Factor-alpha and Associated Immune Markers in Older Cancer SurvivorsK01CA276257 · NCI · UNIVERSITY OF ROCHESTER · PI Nikesha Gilmore · 2023 to 2026
$674k
A Novel Mobile Health Exercise Intervention for Older Patients with Myeloid NeoplasmsK99CA237744 · NCI · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2019 to 2020
$385k
Epigenetic markers, functional status, and exercise in older adults with myeloid neoplasmsR03AG073985 · NIA · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2022 to 2023
$308k
NCI NIH HHS K01 CA276257NCI NIH HHS K99 CA237744NCI NIH HHS R00 CA237744NCI NIH HHS UG1 CA189961NIA NIH HHS R03 AG073985NIA NIH HHS R33 AG059206NIEHS NIH HHS P30 ES001247
6 · The paper itself

Abstract

Tumor necrosis factor (TNF)α is a major regulator of inflammation. However, the epigenetic regulation of TNFα in the context of an exercise intervention among older adults with cancer is understudied. In this exploratory analysis, we used data from a single-arm mobile health (mHealth) exercise intervention among older adults with myeloid malignancies to 1) assess changes in TNFα promoter methylation, TNFα mRNA expression, serum TNFα and other related-cytokine levels after intervention; and 2) assess correlations between blood markers and exercise levels. Twenty patients were included. From baseline to post-intervention, there was no statistical changes in TNFα promoter methylation status at seven CpG sites, TNFα mRNA expression, and serum TNFα levels. Effect sizes, however, were moderate to large for several CpG sites (-120, -147, -162, and -164; Cohen's d = 0.44-0.75). Median serum TNFα sR1 levels increased (83.63, IQR 130.58, p = 0.06; Cohen's d = 0.18) but not the other cytokines. Increases in average daily steps were correlated with increases in TNFα promoter methylation at CpG sites -147 (r = 0.48; p = 0.06) and -164 (r = 0.51; p = 0.04). Resistance training minutes were negatively correlated with TNFα promoter methylation at CpG site -120 (r = -0.62; p = 0.02). All effect sizes were moderate to large. In conclusion, after a mHealth exercise intervention, we demonstrated changes with moderate to large effect sizes in several CpG sites in the TNFα promoter region. Exercise levels were correlated with increases in TNFα promoter methylation. Larger exercise trials are needed to better evaluate TNFα regulation to inform interventions to augment TNFα regulation in order to improve outcomes in older adults with cancer.

Indexed as

CytokinesNeoplasmsAgedDNA MethylationEpigenesis, GeneticHumansRNA, MessengerTumor Necrosis Factor-alphaCytokinesRNA, MessengerTumor Necrosis Factor-alphaCytokinesDNA methylationExerciseInflammationMobile healthMyeloid malignancies

Identifiers

PMID38266886
PMCPMC10923152
OpenAlexW4391233123

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.